EGFR Exon 20 Insertions in NSCLC


In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a specific subset of lung cancer: EGFR exon 20 insertion NSCLC. Joining the podcast is a distinguished panel of clinicians and lung cancer advocates:
Dr. Rosario Garcia Campelo, the Head of Medical Oncology and the Thoracic Tumor Unit Chair at the University Hospital A Coruna, Spain.
Marcia Horn, executive director of the Exon 20 Group and CEO of ICAN, the International Cancer Advocacy Network.
Yonsei University College of Medicine, Professor Byoung-Chul Cho, Director of the Lung Cancer Center at Yonsei Cancer Hospital in Seoul, South Korea.

Stephen Liu
Stephen Liu


Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Rosario Garcia Campelo
Rosario Garcia Campelo


Head of Medical Oncology Department
Thoracic Tumors Unit, University Hospital A Coruña
Biomedical Research Institute (INIBIC, A Coruña)
Byoung Chul Cho
Byoung Chul Cho


Professor, Division of Medical Oncology
Yonsei University College of Medicine
Yonsei Cancer Center
Marcia Horn
Marcia K. Horn, JD
President and CEO
International Cancer Advocacy Network (ICAN)